National Cancer Institute; Notice of Closed Meetings, 30592 [E9-15067]

Download as PDF 30592 Federal Register / Vol. 74, No. 122 / Friday, June 26, 2009 / Notices the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the contract proposals, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Environmental Health Sciences Special Emphasis Panel; Molecular and Oncology Support Services. Date: July 16, 2009. Time: 10 a.m. to 12:30 p.m. Agenda: To review and evaluate contract proposals. Place: NIEHS/National Institues of Health, Keystone Building, 530 Davis Drive, Research Triangle Park, NC 207709, (Telephone Conference Call). Contact Person: RoseAnne M. McGee, Associate Scientific Review Administrator, Scientific Review Branch, Division of Extramural Research and Training, Nat. Institute of Environmental Health Sciences, P.O. Box 12233, MD EC–30, Research Triangle Park, NC 27709, (919) 541–0752, mcgee1@niehs.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.115, Biometry and Risk Estimation—Health Risks from Environmental Exposures; 93.142, NIEHS Hazardous Waste Worker Health and Safety Training; 93.143, NIEHS Superfund Hazardous Substances—Basic Research and Education; 93.894, Resources and Manpower Development in the Environmental Health Sciences; 93.113, Biological Response to Environmental Health Hazards; 93.114, Applied Toxicological Research and Testing, National Institutes of Health, HHS) Dated: June 19, 2009. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. E9–15068 Filed 6–25–09; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Cancer Institute; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which VerDate Nov<24>2008 16:39 Jun 25, 2009 Jkt 217001 would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Cancer Institute Special Emphasis Panel. NCI ARRA Grand Opportunities Cancer Vaccines. Date: August 5–6, 2009. Time: 8 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: Marriott Bethesda North Hotel & Conf. Ctr., Bethesda, MD. Contact Person: Shamala K. Srinivas, PhD, Scientific Review Officer, Research Programs Review Branch, Division of Extramural Activities, National Cancer Institute, 6116 Executive Boulevard, Room 8123, Bethesda, MD 20892. 301–594–1224. ss537t@nih.gov. Name of Committee: National Cancer Institute Special Emphasis Panel. NCI–ARRA Grand Opportunities—Stem Cells. Date: August 5–6, 2009. Time: 8 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: Marriott Bethesda North Hotel and Conf. Ctr., Bethesda, MD. Contact Person: Shakeel Ahmad, PhD, Scientific Review Officer, Research Programs Review Branch, Division of Extramural Activities, National Cancer Institute, NIH, 6116 Executive Boulevard, Room 8139, Bethesda, MD 20892–8328. (301) 594–0114. ahmads@mail.nih.gov. Name of Committee: National Cancer Institute Special Emphasis Panel. NCI ARRA Grand Opportunities—Transcriptional & Translational. Date: August 5–6, 2009. Time: 8 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: Marriott Bethesda North Hotel and Conf. Ctr., Bethesda, MD. Contact Person: Thomas M Vollberg, PhD, Scientific Review Officer, Special Review and Logistics Branch, Division of Extramural Activities, National Cancer Institute, 6116 Executive Boulevard, Room 7142, Bethesda, MD 20892. 301–594–9582. vollbert@mail.nih.gov. Name of Committee: National Cancer Institute Special Emphasis Panel. NCI ARRA Grand Opportunities-Molecular Targets & Cancer Genomics. Date: August 5–6, 2009. Time: 8 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: Marriott Bethesda North Hotel and Conf. Ctr., Bethesda, MD. Contact Person: Adriana Stoica, PhD, Scientific Review Officer, Special Review & Logistics Branch, Division of Extramural Activities, National Cancer Insitute, NIH, 6116 Executive Blvd, Ste 703, Rm 7072, Bethesda, MD 20892–8329. 301–594–1408. Stoicaa2@mail.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.392, Cancer Construction; 93.393, Cancer Cause and Prevention Research; 93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer Centers Support; 93.398, Cancer Research Manpower; 93.399, PO 00000 Frm 00093 Fmt 4703 Sfmt 4703 Cancer Control; 93.701, ARRA Related Biomedical Research and Research Support Awards, National Institutes of Health, HHS) Dated: June 19, 2009. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. E9–15067 Filed 6–25–09; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Cancer Institute; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Cancer Institute Special Emphasis Panel. NCI–ARRA Grand Opportunities—Nanotechnology. Date: July 22–23, 2009. Time: 8 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: Marriott Bethesda North Hotel and Conference Ctr., Bethesda, MD. Contact Person: Peter J. Wirth, PhD, Scientific Review Officer, Research Programs Review Branch, Division of Extramural Activities, National Cancer Institute, 6116 Executive Boulevard, Room 8131, Bethesda, MD 20892–8328. 301–496–7565. pw2q@nih.gov. Name of Committee: National Cancer Institute Special Emphasis Panel. NCI–ARRA Grand Opportunities—Comparative Oncology. Date: August 4–5, 2009. Time: 8 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: Marriott Bethesda North Hotel and Conf. Ctr., Bethesda, MD. Contact Person: Caron A. Lyman, PhD, Scientific Review Officer, Research Programs Review Branch, Division of Extramural Activities, National Cancer Institute, 6116 Executive Blvd., Room 8119, Bethesda, MD 20892–8328. 301–451–4761. lymanc@mail.nih.gov. Name of Committee: National Cancer Institute Special Emphasis Panel. NCI–ARRA Grand Opportunities—Clinical/Translational. E:\FR\FM\26JNN1.SGM 26JNN1

Agencies

[Federal Register Volume 74, Number 122 (Friday, June 26, 2009)]
[Notices]
[Page 30592]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-15067]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Cancer Institute; Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the following 
meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel. NCI ARRA Grand Opportunities Cancer Vaccines.
    Date: August 5-6, 2009.
    Time: 8 a.m. to 5 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Marriott Bethesda North Hotel & Conf. Ctr., Bethesda, MD.
    Contact Person: Shamala K. Srinivas, PhD, Scientific Review 
Officer, Research Programs Review Branch, Division of Extramural 
Activities, National Cancer Institute, 6116 Executive Boulevard, 
Room 8123, Bethesda, MD 20892. 301-594-1224. ss537t@nih.gov.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel. NCI-ARRA Grand Opportunities--Stem Cells.
    Date: August 5-6, 2009.
    Time: 8 a.m. to 5 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Marriott Bethesda North Hotel and Conf. Ctr., Bethesda, 
MD.
    Contact Person: Shakeel Ahmad, PhD, Scientific Review Officer, 
Research Programs Review Branch, Division of Extramural Activities, 
National Cancer Institute, NIH, 6116 Executive Boulevard, Room 8139, 
Bethesda, MD 20892-8328. (301) 594-0114. ahmads@mail.nih.gov.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel. NCI ARRA Grand Opportunities--Transcriptional & 
Translational.
    Date: August 5-6, 2009.
    Time: 8 a.m. to 5 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Marriott Bethesda North Hotel and Conf. Ctr., Bethesda, 
MD.
    Contact Person: Thomas M Vollberg, PhD, Scientific Review 
Officer, Special Review and Logistics Branch, Division of Extramural 
Activities, National Cancer Institute, 6116 Executive Boulevard, 
Room 7142, Bethesda, MD 20892. 301-594-9582. vollbert@mail.nih.gov.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel. NCI ARRA Grand Opportunities-Molecular Targets & Cancer 
Genomics.
    Date: August 5-6, 2009.
    Time: 8 a.m. to 5 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Marriott Bethesda North Hotel and Conf. Ctr., Bethesda, 
MD.
    Contact Person: Adriana Stoica, PhD, Scientific Review Officer, 
Special Review & Logistics Branch, Division of Extramural 
Activities, National Cancer Insitute, NIH, 6116 Executive Blvd, Ste 
703, Rm 7072, Bethesda, MD 20892-8329. 301-594-1408. 
Stoicaa2@mail.nih.gov.

(Catalogue of Federal Domestic Assistance Program Nos. 93.392, 
Cancer Construction; 93.393, Cancer Cause and Prevention Research; 
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer 
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer 
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer 
Control; 93.701, ARRA Related Biomedical Research and Research 
Support Awards, National Institutes of Health, HHS)

    Dated: June 19, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. E9-15067 Filed 6-25-09; 8:45 am]
BILLING CODE 4140-01-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.